CH BIOTECH SER's subsidiary has been granted a loan with a principal amount of up to 180 million yuan
I'm PortAI, I can summarize articles.
CH BIOTECH SER announced that its wholly-owned subsidiary Pengbo (Hainan) has signed a loan agreement with Hainan Rural Commercial Bank, with a maximum loan amount of 180 million yuan. The loan will be used to construct a boron neutron capture therapy center, expected to open by the end of 2025, providing treatment services for cancer patients. The company plans to develop a network of treatment centers covering China with the support of the Boao Lecheng Pilot Zone, creating more revenue
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments